Considering the chronic inflammation microenvironment of T2DM (Rohm et al., 2022), we hypothesized that TADSCs could inhibit peri-implant inflammation, consequently promoting peri-implant osseointegration synergistically, and this effect may be enhanced by Pten inhibition. The gene discussed is PTEN; the disease is type 2 diabetes mellitus.